Join to access to all OVN content. Join for Free
Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?

Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?


Share This Article


If you’re an aspiring MSL, you’re probably thinking a lot about how to master the MSL interview. 🎤 The biggest part of the interview is the presentation you’ll give during the final interview. 📊 One way to really shine on this very important element of the evaluation process is to have a back pocket presentation. 📂 A back pocket presentation? What’s that? 🤔 Well, that’s the topic of this Aspiring MSL Insight.

Michael Pietrack heads up the Medical Affairs recruiting at Kaye/Bassman International and hosts the Pharmaverse Podcast. 🎙️ And the majority of the MSLs we know have a back pocket presentation - a presentation they know by heart. It’s like they can pull it right out of their back pocket and give it to anyone, anywhere. Do you have one of those? 🤓

Why is it important to have a back pocket presentation?

The interview process doesn’t stop for you to develop a presentation and make slides, so having a back pocket presentation will ensure you keep pace with other candidates. ⏱️

Later in your career, you’re going to be busy doing your job, and you just can’t stop your day job to create a presentation, so having a back pocket presentation will help you manage performing at your job while considering new opportunities. 📈

A back pocket presentation allows you to know the data cold, and because you know the topic so well and have researched it so heavily, you’ll be able to present and answer questions with confidence. 💪

Now, it’s true, some companies will provide the topic and the paper you’ll present on, but that doesn’t change the fact that you should still have a back pocket presentation because, most of the time, the company allows you to pick the topic. 📝

So, choose your topic wisely. Make sure that it is on a therapeutic topic that would be relevant to the companies you’re targeting. 🎯 For instance, you don’t want to give a Neurology presentation when going for an Oncology MSL role. So, choose a clinical paper, or some Phase 3 clinical trial data, or a disease state overview that would be relevant to the largest group of the companies you’re targeting. 🔬

Now the best practices of how to ace your presentation is a much larger topic and deserves its own separate videos, so be on the lookout for those. 📹 But we hope that the advice to have a back pocket presentation was helpful. If so, subscribe to the channel and make sure to join our private LinkedIn group called “KBIC Jobs – Medical Affairs.” Thanks! 🙌

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved
OVN Avatar Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD

Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved

Explore OVN